Delivery Order SPE2DB22D1200-SPE2DB25FN3LR
Award Date 7/29/25
Potential Completion Date 7/30/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Vyvanse 20 mg capsules (100-count units) with a ceiling value of $1,469.34. This non-set-aside, competitively awarded contract employs firm fixed pricing and requires completion by July 21, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Vyvanse 30 mg capsules (100-count units) with a ceiling value of $2,675.40. This competitively awarded, firm fixed-price delivery order is set to be completed by July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Vyvanse 30 mg capsules (100-count units) with a contract ceiling value of $3,071.84. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Vyvanse 10 mg capsules (100 count) with a contract value of $2,100.43. This is a firm fixed price delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX valued at $999,999,999.00 through December 2026). The ultimate completion date is scheduled for August 14, 2025,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Vyvanse 50 mg capsules (100-count units) under a firm fixed-price contract valued at $2,196.14. This is a non-set-aside award, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This delivery order is issued against...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Vyvanse 30 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $13,200.69. This is a competitively awarded, non-set-aside delivery order with an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vyvanse 60 mg capsules (100 count) on July 23, 2025, with a ceiling value of $1,456.54 and an ultimate completion date of July 24, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Vyvanse 10 mg capsules (100 count) with a contract value of $1,783.60. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle, is scheduled for completion by July 30, 2025. The award carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the...
- The Defense Logistics Agency awarded a delivery order valued at $7,202.90 to AmerisourceBergen Drug Corp for the supply of Vyvanse 30 mg capsules (100 count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitive, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Vyvanse capsules 50mg under a firm fixed-price contract with a ceiling value of $18,338.85. This competitive award, executed without a set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....